A cost-cost study comparing etanercept with infliximab in rheumatoid arthritis.
about
Practical issues in handling data input and uncertainty in a budget impact analysis.Differential expression of NK receptors CD94 and NKG2A by T cells in rheumatoid arthritis patients in remission compared to active disease.Soluble cytokine receptors in biological therapy.Targeting cytokines in autoimmunity: new approaches, new promise.Treatment of sarcoid granulomatous interstitial nephritis with adalimumab.Review of health economics modelling in rheumatoid arthritis.Cost-effectiveness of TNF-alpha-blocking agents in the treatment of rheumatoid arthritis.InforMatrix: treatment of rheumatoid arthritis using biologicals.Recombinant human hyaluronidase (rHuPH20): an enabling platform for subcutaneous drug and fluid administration.A pharmacoeconomic review of adalimumab in the treatment of rheumatoid arthritis.Critical appraisal of pharmacoeconomic studies comparing TNF-alpha antagonists for rheumatoid arthritis treatment.The economic burden of biological therapy in rheumatoid arthritis in clinical practice: cost-effectiveness analysis of sub-cutaneous anti-TNFalpha treatment in Italian patients.The case of tumour necrosis factor-alpha inhibitors in the treatment of rheumatoid arthritis: a budget impact analysis.
P2860
Q33549234-A5C3987C-B800-4036-91E0-E5AD635BD0B1Q34079261-8A267AE8-C7F1-4912-A8AB-7FF130B7DFB4Q34779777-AFC65692-5035-46C4-9689-DD81582EEC50Q35144028-5ADBA269-3C0C-48C9-AD57-E9DA144DDAF2Q35573936-005EB17A-440A-4198-9898-4BF23AD132C8Q35780357-FC56DF71-976D-4D0B-B029-5F4F6BFA8BEEQ35871855-E3916886-0EA1-412F-89B4-4CB4395A6602Q36573901-50AA042A-65C1-4AB8-9768-801188058162Q36903813-2DB35213-B5A3-49DF-B2D1-4E8B1A02BB3DQ37609399-1B55C4ED-444B-45FD-9EFF-800D92991CFEQ37763121-3289E9DD-7F99-4BBB-9340-8D3915F3DCC5Q43194443-73289B54-3EA0-43C5-9C26-3C8EBB15B8E0Q53860668-01B403A6-31A7-4C35-A82E-D37B34F73F11
P2860
A cost-cost study comparing etanercept with infliximab in rheumatoid arthritis.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
A cost-cost study comparing etanercept with infliximab in rheumatoid arthritis.
@en
A cost-cost study comparing etanercept with infliximab in rheumatoid arthritis.
@nl
type
label
A cost-cost study comparing etanercept with infliximab in rheumatoid arthritis.
@en
A cost-cost study comparing etanercept with infliximab in rheumatoid arthritis.
@nl
prefLabel
A cost-cost study comparing etanercept with infliximab in rheumatoid arthritis.
@en
A cost-cost study comparing etanercept with infliximab in rheumatoid arthritis.
@nl
P2093
P1433
P1476
A cost-cost study comparing etanercept with infliximab in rheumatoid arthritis.
@en
P2093
M J Nuijten
M Koopmanschap
P Engelfriet
P304
P356
10.2165/00019053-200119100-00006
P577
2001-01-01T00:00:00Z
P6179
1036843569